BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17641292)

  • 21. Caenorhabditis elegans LET-767 is able to metabolize androgens and estrogens and likely shares common ancestor with human types 3 and 12 17beta-hydroxysteroid dehydrogenases.
    Desnoyers S; Blanchard PG; St-Laurent JF; Gagnon SN; Baillie DL; Luu-The V
    J Endocrinol; 2007 Nov; 195(2):271-9. PubMed ID: 17951538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and localization of estrogenic type 12 17beta-hydroxysteroid dehydrogenase in the cynomolgus monkey.
    Liu H; Zheng S; Bellemare V; Pelletier G; Labrie F; Luu-The V
    BMC Biochem; 2007 Feb; 8():2. PubMed ID: 17280614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women.
    Luu-The V; Tremblay P; Labrie F
    Mol Endocrinol; 2006 Feb; 20(2):437-43. PubMed ID: 16166196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and characterization of human form 2 type 7 17beta-hydroxysteroid dehydrogenase, a primarily 3beta-keto reductase and estrogen activating and androgen inactivating enzyme.
    Liu H; Robert A; Luu-The V
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):173-9. PubMed ID: 15862963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase.
    Blanchard PG; Luu-The V
    J Endocrinol; 2007 Aug; 194(2):449-55. PubMed ID: 17641292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
    Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of steroidogenesis and steroidogenic enzyme functions.
    Luu-The V
    J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.
    Ito K; Utsunomiya H; Suzuki T; Saitou S; Akahira J; Okamura K; Yaegashi N; Sasano H
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):136-40. PubMed ID: 16406263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
    Aka JA; Mazumdar M; Lin SX
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen biosynthetic pathways in the human prostate.
    Luu-The V; Bélanger A; Labrie F
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):207-21. PubMed ID: 18471780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
    Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
    Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intracrine sex steroid biosynthesis pathways.
    Luu-The V; Labrie F
    Prog Brain Res; 2010; 181():177-92. PubMed ID: 20478438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action.
    Baker ME
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):211-5. PubMed ID: 11165032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
    Yarrow JF; McCoy SC; Borst SE
    Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17beta-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17beta- and 3alpha-hydroxysteroid metabolism.
    Napoli JL
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):103-9. PubMed ID: 11165018
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.